Hospital Policies on Intravenous Vasopressor Administration and Monitoring: A Survey of Michigan Hospitals
Ann Am Thorac Soc
.
2022 Oct;19(10):1769-1772.
doi: 10.1513/AnnalsATS.202203-197RL.
Authors
Elizabeth Munroe
1
,
Dru Claar
1
,
Maximiliano Tamae-Kakazu
2
,
Geneva Tatem
3
,
John Blamoun
4
,
Jakob I McSparron
1
,
Hallie C Prescott
1
5
Affiliations
1
University of Michigan Ann Arbor, Michigan.
2
Spectrum Health Grand Rapids, Michigan.
3
Henry Ford Hospital Detroit, Michigan.
4
MidMichigan Health Midland, Michigan.
5
VA Center for Clinical Management Research Ann Arbor, Michigan.
PMID:
35608405
DOI:
10.1513/AnnalsATS.202203-197RL
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Hospitals*
Humans
Infusions, Intravenous
Michigan
Policy
Vasoconstrictor Agents* / therapeutic use
Substances
Vasoconstrictor Agents